GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sirona Dental Systems Inc (NAS:SIRO) » Definitions » ROE %

Sirona Dental Systems (Sirona Dental Systems) ROE % : 15.19% (As of Dec. 2015)


View and export this data going back to . Start your Free Trial

What is Sirona Dental Systems ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Sirona Dental Systems's annualized net income for the quarter that ended in Dec. 2015 was $205 Mil. Sirona Dental Systems's average Total Stockholders Equity over the quarter that ended in Dec. 2015 was $1,351 Mil. Therefore, Sirona Dental Systems's annualized ROE % for the quarter that ended in Dec. 2015 was 15.19%.

The historical rank and industry rank for Sirona Dental Systems's ROE % or its related term are showing as below:

SIRO's ROE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.25
* Ranked among companies with meaningful ROE % only.

Sirona Dental Systems ROE % Historical Data

The historical data trend for Sirona Dental Systems's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Dental Systems ROE % Chart

Sirona Dental Systems Annual Data
Trend Mar06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.02 13.93 13.68 14.55 14.34

Sirona Dental Systems Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.53 11.65 18.94 13.85 15.19

Competitive Comparison of Sirona Dental Systems's ROE %

For the Medical Instruments & Supplies subindustry, Sirona Dental Systems's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Dental Systems's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sirona Dental Systems's ROE % distribution charts can be found below:

* The bar in red indicates where Sirona Dental Systems's ROE % falls into.



Sirona Dental Systems ROE % Calculation

Sirona Dental Systems's annualized ROE % for the fiscal year that ended in Sep. 2015 is calculated as

ROE %=Net Income (A: Sep. 2015 )/( (Total Stockholders Equity (A: Sep. 2014 )+Total Stockholders Equity (A: Sep. 2015 ))/ count )
=186.2/( (1258.8+1338.2)/ 2 )
=186.2/1298.5
=14.34 %

Sirona Dental Systems's annualized ROE % for the quarter that ended in Dec. 2015 is calculated as

ROE %=Net Income (Q: Dec. 2015 )/( (Total Stockholders Equity (Q: Sep. 2015 )+Total Stockholders Equity (Q: Dec. 2015 ))/ count )
=205.2/( (1338.2+1364.1)/ 2 )
=205.2/1351.15
=15.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2015) net income data. ROE % is displayed in the 30-year financial page.


Sirona Dental Systems  (NAS:SIRO) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2015 )
=Net Income/Total Stockholders Equity
=205.2/1351.15
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(205.2 / 1216.8)*(1216.8 / 1887.8)*(1887.8 / 1351.15)
=Net Margin %*Asset Turnover*Equity Multiplier
=16.86 %*0.6446*1.3972
=ROA %*Equity Multiplier
=10.87 %*1.3972
=15.19 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2015 )
=Net Income/Total Stockholders Equity
=205.2/1351.15
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (205.2 / 269.2) * (269.2 / 266.8) * (266.8 / 1216.8) * (1216.8 / 1887.8) * (1887.8 / 1351.15)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7623 * 1.009 * 21.93 % * 0.6446 * 1.3972
=15.19 %

Note: The net income data used here is four times the quarterly (Dec. 2015) net income data. The Revenue data used here is four times the quarterly (Dec. 2015) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Sirona Dental Systems ROE % Related Terms

Thank you for viewing the detailed overview of Sirona Dental Systems's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Dental Systems (Sirona Dental Systems) Business Description

Traded in Other Exchanges
N/A
Address
Sirona Dental Systems Inc was founded in 1997 and completed an initial public offering of its common stock on July 1, 1997. The Company is a manufacturer of high-quality, dental equipment, and is engaged in developing, manufacturing and marketing solutions for dentists around the world. The Company provides products in each of its four product segments: Dental CAD/CAM Systems; Imaging Systems; Treatment Centers; and Instruments. The Company markets its products globally to dental practices, clinics and laboratories through an international network of distributors. The dental market encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Recent technological advancements in the dental equipment industry include 3D radiography, digital radiography, CAD/CAM technology, intra oral cameras and periodontal instruments. The market it serves comprises the whole working environment of a dentist or dental technician, including the dentist's chair, lights, imaging systems and dental CAD/CAM systems, instruments, as well as practice furniture and other dental or lab-based systems. Dental CAD/CAM Systems address the market for dental restorations, which includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic, metal or composite blocks. The Company has developed a range of imaging systems for 2D and 3D, panoramic and intra-oral applications that allow the dentist to accommodate the patient in a more efficient manner. Treatment Centers comprise products from basic dentist chairs to sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. In July 2008, the Company launched its new TENEO Treatment Center, which combines technology with a timeless design that provides both patient and dentist with the ultimate in convenience and comfort. The Company offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis. The instruments are supplemented by multi-function tips, supply and suction hoses, as well as care and hygiene systems for instrument preparation. Its product information is actively made available to business publications, dentists, journals, professional organizations and dental schools, and its website. Sirona distributes its products globally to dental practices, clinics and laboratories through an international network of more than 480 distributors. The Companys registered trademarks include, Sirona, CEREC, Orthophos, Heliodent, inLab, CDR, and Schick. It competes with different companies which include international companies as well as smaller companies that compete regionally or on a narrower product line. The Company is subject to government regulations applicable to all businesses
Executives
Kraemer Harry M Jansen Jr director DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Arthur D Kowaloff director DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Walter Petersohn officer: Executive VP of Sales C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
David Beecken director DENTSPLY SIRONA INC, 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Thomas Jetter director DENTSPLY SIRONA INC, 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Ulrich Michel officer: CFO and Exec. Vice President CHAUSEE DE WAVRE, 1789, CARE OF WABCO HOLDINGS INC, BRUSSELS C9 1160
Rainer Berthan officer: Executive VP C/O SIRONA DENTAL SYSTEMS, INC., FABRIKSTRASSE, BENSHEIM 2M 31D-64625
Jeffrey Slovin director, officer: Chief Executive Officer DENTSPLY SIRONA INC., 30-30 47TH AVE, SUITE 500, LONG ISLAND CITY NY 11101
Jonathan I Friedman officer: General Counsel and Secretary DENTSPLY SIRONA INC., 30-30 47TH AVENUE, SUITE 500, LONG ISLAND CITY NY 11101
Timothy P Sullivan director THREE FIRST NATIONAL PLZ, SUITE 3800, CHICAGO IL 60602
Simone Blank director, officer: Executive VP and CFO C/O SIRONA, WASSERFELDSTRASSE 30 A-5020, SALZBURG C4 5020
Nicholas W Alexos director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Stephen Rosenberg 10 percent owner 1004 FARNAM STREET, SUITE 400, OMAHA NE 68102
Uri Landesman director 230 PARK AVENUE, NEW YORK NY 10169

Sirona Dental Systems (Sirona Dental Systems) Headlines